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ABSTRACT 
Creatine monohydrate has become one of the most popular ergogenic sport supplements used 
today. It is a  nonessential dietary compound that is both endogenously synthesized and naturally 
ingested through diet. Creatine ingested through supplementation has been observed to be 
absorbed into the muscle exclusively by means of a creatine transporter, CreaT1.  The major 
rationale of creatine supplementation is to maximize the increase within the intracellular pool of 
total creatine (creatine + phosphocreatine).  There is much evidence indicating that creatine 
supplementation can improve athletic performance and cellular bioenergetics, although 
variability does exist.  It is hypothesized that this variability is due to the process that controls 
both the influx and efflux of creatine across the cell membrane, and is likely due to a decrease in 
activity of the creatine transporter from various compounding factors.  Furthermore, additional 
data suggests that an individual’s initial biological profile may partially determine the efficacy of 
a creatine supplementation protocol.  This brief review will examine both animal and human 
research in relation to the regulation and expression of the creatine transporter (CreaT).  The 
current literature is very preliminary in regards to examining how creatine supplementation 
affects CreaT expression while concomitantly following a resistance training regimen.  In 
conclusion, it is prudent that future research begin to examine CreaT expression due to creatine 
supplementation in humans in much the same way as in animal models.  Journal of the 
International Society of Sports Nutrition.  3(1): 60-65, 2006. 
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INTRODUCTION 
 
Creatine monohydrate, or methyl guanidine-
acetic acid, has become one of the most popular 
ergogenic sport supplements used today.   
Creatine was first discovered in 1835 by a 
French scientist, Chevreul, followed by the first 
research trials occurring within the early 1900’s 
on the fate of administered creatine 
1. At this 
time both humans 
2 and animals
 3 were studied 
but it wasn’t until the 1990’s that it was finally 
determined that creatine supplementation 
increased the pool of metabolically-active 
creatine in muscle 
4. Once the physiological 
relevance of the creatine-phosphate bioenergetic 
pathway was discovered, much research began 
exploring how creatine supplementation may 
enhance athletic performance.  Although beyond 
the scope of this review, it should also be noted 
that creatine supplementation may also benefit 
individuals diagnosed with various 
neuromuscular disorders and medical conditions. 
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Creatine is a nonessential dietary compound that 
is both endogenously synthesized, primarily in 
the liver, and naturally ingested through 
omnivorous diets, with the greatest natural 
quantity of creatine present in red meats. 
Creatine synthesized from the liver is released 
into the bloodstream and then taken up by 
muscle fibers predominately by way of a 
sodium-chloride dependent creatine transporter, 
CreaT1 
5. There are actually two isoforms of 
creatine transporters, CreaT1 and CreaT2, of 
which the latter is primarily active and present 
within the testes 
6. Creatine ingested through 
supplementation has been observed to be 
absorbed into the muscle exclusively by means 
of CreaT1.  Therefore, creatine transporter 
discussion during the remainder of this 
manuscript will refer to CreaT1 as CreaT, since 
muscle fibers are of the greater focus.    
 
It has been observed that creatine uptake is 
regulated by a variety of mechanisms. Speer et 
al. discussed that phosphorylation and 
glycosylation of the creatine transporter, in 
addition to changes in the extracellular and 
intracellular creatine content, may result in a 
means of regulation of the CreaT protein, which 
in turn, would affect creatine uptake rates 
7. 
Walzel et al. observed that there may be an 
existence of not only cytosolic, but also a 
mitochondrial creatine pool, through the 
observance of CreaT isoforms within the 
mitochondria 
8. These researchers concluded 
that the mitochondria “may represent a major 
compartment of creatine transporter localization, 
thus providing a new aspect to the current debate 
about the existence and whereabouts of 
intracellular creatine and PCr compartments.” 
 
CREATINE SUPPLEMENTATION 
 
The major rationale of creatine supplementation 
is to maximize the increase within the 
intracellular pool of total creatine (creatine + 
phosphocreatine). The intracellular   
concentration of phosphocreatine (PCr) plays a 
significant role during the immediate 
bioenergetic system, which is most active during 
exercise at high intensity, short duration, and 
repeated bouts of physical activity. Through the 
depletion of intracellular PCr stores, the 
intracellular concentration of adenosine 
triphosphate (ATP), a vital molecule necessary 
for muscle contraction, is maintained and 
replenished.  This occurs via a freely reversible 
reaction in which PCr phosphorylates adenosine 
diphosphate (ADP) to replenish ATP stores, 
catalyzed via the enzyme, creatine kinase. PCr 
levels within the muscle are almost 3 to 4 times 
more abundant than intramuscular ATP stores. 
While PCr is more copious than ATP, the rate in 
which ATP is utilized is likely to exceed the 
overall energy substrate regeneration necessary 
at activities of high intensity.  However, the PCr 
supply is sufficient in providing a temporary 
ATP source until other bioenergetic systems 
reach maximal rates.  
 
There is much evidence indicating that creatine 
supplementation can improve athletic 
performance and cellular bioenergetics. Within 
the literature, the most common creatine 
supplementation dosing regimen, indicating a 
significant increase in intracellular PCr, is a 
loading phase of approximately 20 g/day for 5-7 
days which is usually followed by a maintenance 
phase of 5 g/day for a period of several weeks 
26. 
However, this absolute dosing regimen may not 
be best. Instead, a relative amount should be 
used, based on either total body mass or fat free 
mass that yields approximately 20 g/day (e.g. 
0.3 g/kg/day for a 70 kg individual).  This 
relative dosing regimen is based on the premise 
that creatine uptake will most likely differ in 
regards to differences in muscle mass.  
Nevertheless, independent of which dosing 
strategy is followed, some researchers have 
observed no improvement in either increasing 
intramuscular creatine or performance measures 
via creatine supplementation. It is hypothesized 
that this variability is due to the process that 
controls both the influx and efflux of creatine 
across the cell membrane, and is likely due to a 
decrease in activity of CreaT from various 
compounding factors, which will be discussed 
later in this review. 
 
ANIMAL RESEARCH 
 
In order to begin discovering exactly how CreaT 
is regulated, animal research, primarily in rats, 
was studied through creatine supplementation. Journal of the International Society of Sports Nutrition. 3(1): 60-66, 2006. (www.theissn.org) 
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Guerrero-Ontiveros and Wallimann 
9 examined 
rats that were treated with a creatine analogue, 
β-Guanidinoproprionic acid (β-GPA), which 
acts to deplete the intracellular creatine pool.  β-
GPA competitively competes with both creatine 
uptake and creatine kinase activity. Following β-
GPA treatment, creatine transport activity 
actually increased, resulting in an increased 
uptake of supplemented creatine 
9. Additionally, 
it appears that creatine uptake is optimized by 
use of a “transport site specifically adapted to 
interact with an amidine group 
10.”
  Guerrero-
Ontiveros and Wallimann also discovered that 
when the rats were supplemented with creatine 
for 3-6 months, a reduced expression of creatine 
transporter isoforms and a reduced creatine 
uptake occurred 
9. These findings suggest that 
when extrapolated to human athletes that it 
would be: 1) undesirable to consume creatine for 
an extended amount of time to avoid down-
regulation of the creatine transporter; and 2)  it 
would also be advisable to avoid consuming 
extremely high doses of creatine, as this would 
likely down-regulate creatine transport over 
time.  However, the dosage used within the rats 
has been reported to be much greater than when 
applied to humans.  Therefore, it is our view that 
the results of this study should be interpreted 
with caution, as the lower typical dosing 
regimens in humans may not display such a 
marked decline in creatine uptake or CreaT 
down-regulation through the typical moderate 
doses of creatine supplementation.  
 
  Murphy et al. examined how CreaT mRNA, 
CreaT protein, and total creatine (TCr) content 
varies between oxidative and glycolytic muscle 
fibers 
11. Muscle sampling, enzymatic assays, 
immunoblotting, immunohistochemistry, and 
real-time PCR were utilized to gather the data.  
The results indicated that TCr content was 
significantly greater in glycolytic (white) muscle 
fibers than in the oxidative (red) muscle.  In 
contrast, CreaT protein content was greatest in 
oxidative muscle when compared to glycolytic 
fibers.  With all muscle types, CreaT protein 
content was situated predominately at the 
sarcolemma, with evidence that some of the 
protein was also located internally.  Lastly, real-
time PCR indicated that no difference was 
observed in regards to the expression of CreaT 
mRNA between all fiber types.  This data 
suggests that oxidative muscle has an augmented 
ability to transport creatine, due to a greater 
CreaT protein content and a decreased TCr 
intracellular quantity.  The authors also 
discussed that it is most likely that intracellular 
creatine rather than PCr concentration that 
determines the regulation of creatine uptake and 
CreaT activity and expression.  It is plausible 
that as free intracellular creatine content 
increases, AMP-activated protein kinase 
(AMPK) will “initiate a signaling pathway 
leading to alterations in gene expression.” 
  
Wang et al. discussed that the CreaT functions 
similarly to neurotransmitter and amino acid 
transport classifications 
12. Since tyrosine   . 
phosphorylation is a primary mechanism in 
which neurotransmitter transport occurs, and 
that phosphorylation is known to regulate 
sodium-potassium-ATPase activity, creatine 
transport may be resultantly affected. Therefore, 
these researchers examined whether changes in 
the intracellular levels of free Cr via 
supplementation are coupled with tyrosine 
phosphorylation of the CreaT.  The authors 
investigated this mechanism during sepsis; 
although this is beyond the scope of this review, 
it is interesting that oral creatine 
supplementation decreased tyrosine 
phosphorylation of the CreaT.     
  
The literature discussed thus far dealt primarily 
with how the CreaT is regulated after creatine 
has been absorbed into the bloodstream.  Peral et 
al. took a different approach by examining 
intestinal CreaT activity following 
supplementation 
13. Results from this research 
indicate that not only is the CreaT sodium 
dependent, but it is also partially chloride 
dependent.  It was observed that increasing the 
chloride concentration significantly increased 
creatine uptake.  The authors note that prior to 
this study, only sodium dependence was focused 
upon, with no evaluation of chloride’s role.  It is 
estimated that two sodium molecules and one 
chloride molecule are necessary for creatine 
transport.  An additional finding concluded that 
β-GPA inhibited intestinal absorption most 
when compared to other creatine uptake 
inhibitors. Journal of the International Society of Sports Nutrition. 3(1): 60-66, 2006. (www.theissn.org) 
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An individual’s muscle fiber type may also 
dictate the response of creatine uptake 
14. Brault 
and Terjung 
14 examined rat hindlimbs and their 
response to creatine supplementation.  Creatine 
uptake rates and CreaT protein content were 
observed to be greatest in highly oxidative 
muscle and lowest in glycolytic fibers, whereas, 
CreaT mRNA was not significantly different 
between all fiber types.  It was also found that 
creatine uptake was depressed in rats having a 
lower creatine and sodium concentration.   
Lastly, creatine uptake was inversely related to 
intracellular creatine content.   
 
Another study conducted by Brault et al. 
15 
evaluated how CreaT expression and the rate of 
creatine uptake were affected by a “long-term 
altered creatine environment designed to 
supplement, deplete, and replete intracellular 
total creatine 
15.”
  It was hypothesized that 
creatine supplementation would result in both a 
decreased uptake of creatine and CreaT 
expression, whereas the utilization of β-GPA 
would result in vice versa. The results indicated 
that changes within the intracellular creatine 
levels significantly affect muscle fibers 
portraying more oxidative properties when 
intracellular creatine levels are low.  For 
example, CreaT protein expression was 
increased following creatine depletion with the 
most significant changes in oxidative muscle 
fibers.  In contrast, during repletion, lower 
creatine uptake rates occurred with no change in 
CreaT protein content. The authors speculated 
that the regulation of creatine uptake is possibly 
affected by other mechanisms than the 
expression of CreaT. Since the research protocol 
implemented high creatine feeding prior to 
depletion, this may have resulted in a reduction 
in CreaT protein preceding repletion. The results 
from this study have provided a potential 
hypothesis when applied to humans: 1) During 
creatine supplementation, creatine uptake would 
most likely be more pronounced in individuals 
possessing the lowest initial intracellular 
creatine concentration; and 2)  Humans with a 
lower intracellular creatine level would not be 
expected to uptake creatine as effectively.  Both 
of these scenarios assume that all individuals 
obtained similar plasma creatine levels from 
creatine supplementation.  This warrants future 
research since, unfortunately, most creatine 
supplementation research uses an absolute dose 
rather than a relative quantity based upon total 
body mass or fat-free mass. 
 
HUMAN RESEARCH 
 
Human research on CreatT1 expression has been 
fairly limited to health and disease issues 
16-19. 
However, some studies have examined how Cr 
supplementation in humans affects CreaT gene 
expression in vegetarians 
20, males versus 
females 
21, and between young and elderly 
individuals 
22. 
  
In regard to individuals diagnosed with 
neuromuscular disorders, it has been observed 
that total creatine and PCr levels are decreased 
in myopathies 
23. Tarnopolsky et al. selected 
patients portraying this diagnosis and measured 
skeletal muscle CreaT protein in addition to 
sarcomeric mitochondrial creatine kinase protein 
content (mtCK) 
18. CreaT protein content was 
significantly lower for those with myopathies.   
However, mtCK varied between participants.   
These results indicate that lower levels of CreaT 
protein is the major contributor to decreased 
total creatine and PCr levels in myopathies, and 
that creatine supplementation may provide a 
beneficial treatment to restore these stores.     
Pyne-Geithman et al. conducted a descriptive 
case study on an individual that carried a 
mutation of the X-linked creatine-transporter 
gene 
16. This type of mutation generally results 
in virtually complete creatine depletion in the 
brain, although observed musculoskeletal and 
cardiac function remain as normal. A muscle 
biopsy was excised from the patient following 
surgery for scoliosis and compared to three other 
archived samples to serve as a control.  It was 
concluded that muscle was not affected by the 
CreaT mutation since no abnormalities were 
seen in creatine concentration, muscle histology, 
and electron transport chain activity.  The 
authors suggested that there are different 
methods, as well as several factors, that allow 
creatine uptake in the muscle when compared to 
the brain.  Creatine synthesis was also ruled out 
since synthesis has not been observed in skeletal 
muscle in humans nor in animal models.  This Journal of the International Society of Sports Nutrition. 3(1): 60-66, 2006. (www.theissn.org) 
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research clarifies that muscle and brain respond 
differently to creatine transport. 
 
Since meat is the primary dietary source for 
creatine, the examination of vegetarians may 
provide a unique aspect to creatine metabolism 
research.  Watt et al. examined how five days of 
creatine supplementation affects vegetarians 
versus omnivores in regards to total creatine 
content and CreaT expression 
20. Results 
indicated that vegetarians had a lower initial 
total creatine concentration, and during 
supplementation, both groups significantly 
increased total creatine levels. However, 
vegetarians’ total creatine content increased to a 
greater extent.  Therefore, during a creatine 
loading protocol, vegetarians appear to possess a 
greater ability to take up creatine when 
compared to their omnivorous counterparts. 
 
Previous research has concluded that there is no 
gender difference in the total creatine content in 
muscle, either before or after supplementation.  
Although this suggests that CreaT activity is 
unlikely to differ between genders, no research 
has directly investigated this.  Murphy et al. 
chose to focus upon whether there is a difference 
between genders in CreaT mRNA and protein in 
healthy, young adults 
21. Two groups, separated 
by gender, had a muscle biopsy taken, which 
was then analyzed for CreaT mRNA, CreaT 
protein, and total creatine content.  The results 
failed to show any differences between genders 
in neither total creatine content nor CreaT 
protein quantity, with CreaT protein expression 
greatest in type I fibers than in type II muscle 
fibers.  Lastly, results concluded that there was 
an inverse relationship between total creatine 
content and CreaT protein content for females.  
It was noted that this relationship was also very 
close to being significant for males as well; after 
an outlier was removed, both genders proved 
statistically significant.  Therefore, as total 
creatine content increases, the creatine 
transporter content decreases, and vice versa.   
This research exhibits the same indirect 
relationship that has been observed in previous 
animal models.  The authors suggest that muscle 
fiber type needs to be taken into account for 
future research measuring CreaT expression, 
since type I fibers tend to have a greater 
abundance of CreaT protein. 
 
Previous animal research has repeatedly shown a 
down regulation in CreaT expression following 
long-term creatine supplementation.  It is argued 
that since the animal doses of creatine were 
much higher when equated to humans, down-
regulation of the CreaT may be very slight or 
nonexistent when applied to a typical moderate 
dosing regimen in human individuals.   
Tarnopolsky et al. chose to examine this 
particular issue in order to “determine whether a 
moderate-term (2 month) creatine monohydrate 
supplementation protocol would down-regulate 
the total amount of CreaT protein in young and 
elderly individuals participating in a resistance 
exercise training protocol 
22.”
 Results concluded 
that intracellular creatine levels were 
significantly elevated among all groups.   
Additionally, no alteration in CreaT protein 
content was apparent with either creatine 
supplementation or exercise training.  CreaT 
mRNA was not affected following acute creatine 
loading.  In addition to Murphy’s work,
21 no 
difference between genders were observed in 
relation to CreaT protein or CreaT mRNA 
abundance.  In conclusion, creatine  . 
supplementation with a simultaneous resistance 
training protocol effectively raised the 
intracellular creatine content and did not result 
in a decrease in CreaT protein or CreaT mRNA.       
 
RESPONDERS  VS. NONRESPONDERS  
 
Most studies have reported an increase in 
intramuscular creatine levels with 
supplementation; however, variability does 
exist.  This poses the possible scenario of 
“responders” versus “nonresponders” to creatine 
supplementation.  It is hypothesized that much 
of this variability lies within the regulation and 
activity of the creatine transporter.   
Unfortunately, most of the limited creatine 
supplementation research conducted 
investigating the expression of CreaT has been 
through animal models, as previously noted.  
Greenhaff et al observed that approximately 20-
30% of participants following a creatine loading 
regime did not respond with an increase in 
intracellular creatine 
24. This was defined as Journal of the International Society of Sports Nutrition. 3(1): 60-66, 2006. (www.theissn.org) 
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resting total muscle creatine levels less than 
10mmol/kg following a 5 day creatine loading 
phase at 20g/d.  Responders were then classified 
as achieving a 20mmol/kg increase following 
the loading phase.  Recently, Syrotuik and Bell 
25 conducted a descriptive profile of individuals 
portraying Greenhaff’s classification of 
“responder” and “non-responder” 
characteristics. Results of this study concluded 
that the responders generally: 1) possessed a 
lower initial quantity of intramuscular creatine 
and were able to absorb and take up a greater 
amount through supplementation; 2) had a 
greater percentage of type II fibers; 3) had a 
greater fiber cross sectional area; and 4) 
possessed more fat-free mass.  This data 
suggests that an individual’s biological profile 
may partially determine the efficacy of a 
creatine supplementation protocol. 
A significant amount of literature has developed 
in regards to the most effective means to 
enhance creatine uptake.  Adding creatine with a 
carbohydrate source has been observed to 
enhance uptake, primarily through the effect of 
an insulin response 
4,26. Additionally, some 
research in cell culture has indicated that 
combining creatine and sodium may additionally 
enhance creatine uptake via the manipulation of 
increasing the gradient in which the CreaT 
functions 
27. The current literature is very 
preliminary in relation to examining how 
creatine supplementation affects CreaT 
expression while concomitantly following a 
resistance training protocol.  In conclusion, it is 
prudent that future research begin to examine 
CreaT expression due to creatine 
supplementation in humans in much the same 
way as in animal models. 
 
 
REFERENCES 
 
1.  Mesa JLM, Ruiz JR, Gonzalez-Gross MM, et al. Oral creatine supplementation and skeletal muscle metabolism in physical 
exercise. Sports Med. 2002;32(14):903-944. 
2.  Chanutin A. The fate of creatine when administered to man. J Biol Chem. 1926;67:29-37. 
3.  Chanutin A. A study of the effect of creatine on growth and its distribution in the tissues of normal rats. J Biol Chem. 
1927;75:547-557. 
4.  Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine 
supplementation. Clin Sci. 1992;83:367-374. 
5.  Persky AM, Brazeau GA, Hochhaus G. Pharmacokinetics of the dietary supplement creatine. Clin Pharmacokinet. 
2003;42(6):557-574. 
6.  Snow RJ, Murphy RM. Creatine and the creatine transporter: A review. Mol Cell Biochem. 2001;224:169-181. 
7.  Speer O, Neukomm LJ, Murphy RM, et al. Creatine transporters: A reappraisal. Mol Cell Biochem. 2004;256/257:407-424. 
8.  Walzel B, Speer O, Zanolla E, et al. Novel mitochondrial creatine transport activity. Implications for intracellular creatine 
compartments and bioenergetics. J Biol Chem. 2002;277:37503-37511. 
9.  Guerrero-Ontiveros ML, Wallimann T. Creatine supplementation in health and disease. Effects of chronic creatine ingestion 
in vivo: Down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol  Cell Biochem. 
1988;184:427-437. 
10.  Fitch CD, Shields RP, Payne WF, et al. Creatine metabolism in skeletal muscle. Specificity of the creatine entry process. J 
Biol Chem. 1968;243:2024-2027. 
11.  Murphy R, McConell G, Cameron-Smith D, et al. Creatine transporter protein content, localization, and gene expression in 
rat skeletal muscle. Am J Physiol Cell Physiol. 2001;280:C415-C422. 
12.  Wang W, Jobst MA, Bell B, et al. Cr supplementation decreases tyrosine phosphorylation of the CreaT in skeletal muscle 
during sepsis. Am J Physiol Endocrinol Metab. 2001;282:E1046-E1054. 
13.  Peral MJ, Garcia-Delgado M, Calonge ML, et al. Human, rat and chicken small intestinal Na
+– Cl
- –creatine transporter: 
Functional, molecular characterization and localization. Journal of Physiology. 2002;545(1):133-144. 
14.  Brault JJ, Terjung RL. Creatine uptake and creatine transporter expression among rat skeletal muscle fiber types. Am J 
Physiol Cell Physiol. 2003;284:C1481-C1489. 
15.  Brault JJ, Abraham KA, Terjung RL. Muscle creatine uptake and creatine transporter expression in response to creatine 
supplementation and depletion. J Appl Physiol. 2003;94:2173-2180. 
16.  Pyne-Geithman GJ, DeGrauw TJ, Cecil KM, et al. Presence of normal creatine in the muscles of a patient with a mutation in 
the creatine transporter: A case study. Mol Cell Biochem. 2004;262:35-39. 
17.  DeGrauw TJ, Cecil KM, Byars AW, et al. The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem. 
2004;244:45-48. 
18.  Tarnopolsky MA, Parshad A, Walzel B. Creatine transporter and mitochondrial creatine kinase protein content in 
myopathies. Muscle and Nerve. 2000;24:682-688. Journal of the International Society of Sports Nutrition. 3(1): 60-66, 2006. (www.theissn.org) 
 
66
19.  Guerrero-Ontiveros ML, Wallimann T. Creatine supplementation in health and disease. Effects of chronic creatine ingestion 
in vivo: Down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol  Cell Biochem. 
1998;184:427-437. 
20.  Watt KKO, Garnham AP, Snow RJ. Skeletal muscle total creatine content and creatine transporter gene expression in 
vegetarians prior to and following creatine supplementation. International Journal of Sport Nutrition and Exercise 
Metabolism. 2004;14:517-531. 
21.  Murphy RM, Tunstall RJ, Mehan KA, et al. Human skeletal muscle creatine transporter mRNA and protein expression in 
healthy, young males and females. Mol Cell Biochem. 2003;244:151-157. 
22.  Tarnopolsky M, Parise G, Fu MH, et al. Acute and moderate-term creatine monohydrate supplementation does not affect 
creatine transporter mRNA or protein content in either young or elderly humans.  Mol Cell Biochem. 2003;244:159-166. 
23.  Argov Z, Taivassalo T, De Stefano N, et al. Intracellular phosphates in inclusion body myositis – A 
31P magnetic resonance 
spectroscopy study. Muscle Nerve. 1998;21:1523-1525. 
24.  Greenhaff PL, Bodin K, Soderlund K, et al. Effect of oral creatine supplementation on skeletal muscle phosphocreatine 
resynthesis. Am J Physiol. 1994;266: E745-E730. 
25.  Syrotuik DG, Bell GJ. Acute creatine monohydrate supplementation: A descriptive physiological profile of responders vs. 
nonresponders. J Strength Cond Res. 2004;18(3):610-617. 
26.  Green AL, Hultman E, Macdonald IA, et al. Carbohydrate ingestion augments skeletal muscle creatine accumulation during 
creatine supplementation in humans. Am J Physiol. 1996;271:E821-826. 
27.  Odoom JE, Kemp GJ, and Radda GK. The regulation of total creatine content in a myoblast cell line. Mol Cell Biochem. 
1996;158:179-188. 
 